| 14/11/2019 |
Final Share Issue to La Jolla Cove – Appendix 3B |
| 28/12/2012 |
Change in Director’s Interest – M Rogers |
| 14/12/2012 |
Change in Director’s Interest – M Halasz |
| 04/12/2012 |
Change in Director’s Interest – M Halasz |
| 04/12/2012 |
Change in Director’s Interest – M Rogers |
| 23/11/2012 |
AGM presentation |
| 23/11/2012 |
Result of Meeting |
| 20/11/2012 |
Investor Presentation |
| 09/11/2012 |
Change in Director’s Interest – M Rogers |
| 07/11/2012 |
Change in Director’s Interest – D King |
| 07/11/2012 |
Change in Director’s Interest – M Halasz |
| 29/10/2012 |
Amended Top 20 Option Holders |
| 29/10/2012 |
Dispatch of Options Entitlements Offer Holding Statements |
| 24/10/2012 |
$545K Options Rights Issue Completed |
| 24/10/2012 |
Annual Report to Shareholders |
| 24/10/2012 |
Notice of Annual General Meeting and Proxy Form |
| 22/10/2012 |
Appendix 4C – quarterly |
| 02/10/2012 |
$748K R&D Tax Credit Received |
| 02/10/2012 |
Change in Director’s Interest – M Halasz |
| 30/09/2012 |
Appendix 4E and Preliminary Final Report |
| 20/09/2012 |
Initial Director’s Interest Notice – M Rogers |
| 19/09/2012 |
Appointment of Director |
| 14/09/2012 |
Underwritten Non-Renounceable Pro-Rata Offer and Placement of Options |
| 13/09/2012 |
évolis® Hair Growth Products Exceed Distribution Targets |
| 04/09/2012 |
Exclusive Distributor Appointed for évolis® |
| 28/08/2012 |
Initial Director’s Interest – G Kaufman |
| 27/08/2012 |
Appointment and Resignation of Directors |
| 21/08/2012 |
Appendix 3B |
| 06/08/2012 |
Appointment of Joint Company Secretary |
| 30/07/2012 |
Cellmid News |
| 27/07/2012 |
Appendix 3B |
| 26/07/2012 |
Midkine Ischemia Patent Allowed in US |
| 23/07/2012 |
Appendix 4C |
| 12/07/2012 |
Change of Director’s Interest Notice – M Halasz |
| 25/06/2012 |
2nd Midkine Conference |
| 07/06/2012 |
Appendix 3B |
| 30/05/2012 |
évolis to be sold at Terry White |
| 28/05/2012 |
Results of Meeting |
| 25/05/2012 |
Change in substantial holding |
| 11/05/2012 |
Ceasing to be a substantial holder |
| 07/05/2012 |
Appendix 3B |
| 07/05/2012 |
Treg Antibody Patent Allowed in USA |
| 30/04/2012 |
Notice of Extraordinary General Meeting / Proxy Form |
| 26/04/2012 |
Appendix 4C |
| 24/04/2012 |
Cellmid Completes $1.5M Placement |
| 19/04/2012 |
Commercial website launched for évolis™ |
| 18/04/2012 |
USA Antibody Patent for Adhesion Allowed |
| 16/04/2012 |
Appendix 3B |
| 04/04/2012 |
Appendix 3B |
| 03/04/2012 |
Change of Director’s Interest Notice – R Beaumont |
| 29/03/2012 |
Appendix 3B |
| 29/03/2012 |
Media Launch of évolis™ Hair Products |
| 16/03/2012 |
Appendix 3B |
| 13/03/2012 |
Change of Director’s Interest Notice – M Halasz |
| 06/03/2012 |
Appendix 3B |
| 05/03/2012 |
Annual Report on Celera (Quest) License |
| 28/02/2012 |
Appendix 3B |
| 28/02/2012 |
Appendix 4D and Half Year Accounts |
| 20/02/2012 |
Appendix 3B |
| 20/02/2012 |
Notice of Change of Interest of Substantial Holder |
| 15/02/2012 |
TGA Registration and Launch of Cellmid’s évolis™ Products |
| 13/02/2012 |
La Jolla Funding Agreement Termination |
| 30/01/2012 |
Appendix 3B |
| 30/01/2012 |
Appendix 4C |
